Haroon A. Choudry

University of Pittsburgh Medical Center — United States

Medicine · Health Sciences

36h-index4.4kcitations152works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Intraperitoneal and Appendiceal Malignancies(86), Appendicitis Diagnosis and Management(50), Ovarian cancer diagnosis and treatment(45), Hepatocellular Carcinoma Treatment and Prognosis(16), Pancreatic and Hepatic Oncology Research(13)

Publications150 total

ASO Visual Abstract: Intratumoral Mucolytic Therapy for Unresectable Pseudomyxoma Peritonei: Results of a Single-Center Expanded Access Program
Annals of Surgical Oncology·2026
Outcome Analysis of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion (HITHOC) for Pseudomyxoma Peritonei with Pleural Metastasis
Annals of Surgical Oncology·2025· 2 cited
Efficacy and safety of intraperitoneal paclitaxel-based regimens in patients with gastric cancer and peritoneal metastasis: A systematic review and meta-analysis
European Journal of Surgical Oncology·2025
Predicting Severe Postoperative Complications after CRS‐HIPEC: An Externally Validated Machine‐Learning Tool
World Journal of Surgery·2025· 2 citedOpen Access
TP53 Alterations Are an Independent Adverse Prognostic Indicator in Pseudomyxoma Peritonei of Appendiceal Origin Following Cytoreductive Surgery and Intraperitoneal Chemotherapy
Applied immunohistochemistry & molecular morphology·2025
Patient Perspectives of Fertility Following Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Improved Perioperative Counseling
Journal of Surgical Research·2025· 2 citedOpen Access
ASO Visual Abstract: Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes
Annals of Surgical Oncology·2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Cancer Cell·2024· 42 citedOpen Access
Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes
Annals of Surgical Oncology·2024· 5 cited
Microsatellite instability should not determine candidacy for cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with peritoneal metastases from colorectal cancer
Journal of Gastrointestinal Surgery·2024· 1 cited
Pathologic response rates to neoadjuvant pembrolizumab in locally advanced (LA) resectable cutaneous squamous cell carcinoma (cSCC).
Journal of Clinical Oncology·2024· 8 cited
Reduction in Postoperative Opioid Requirement Associated With Use of the NSS-2® Bridge Device, a Disposable Auriculo-Nerve Field Stimulator, and Factors Affecting the Response in Cancer Patients Undergoing Abdominal Surgical Procedures
2024Open Access
Remnant completion cholecystectomy is on the rise: Don't three-putt it
HPB·2024· 1 citedOpen Access
A machine learning approach for predicting textbook outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
World Journal of Surgery·2024
ASO Visual Abstract: Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
Annals of Surgical Oncology·2024
Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
Annals of Surgical Oncology·2024· 9 cited
Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma
SSRN Electronic Journal·2024Open Access
Remnant cholecystectomy: a twenty-year institutional experience
HPB·2024
P133 Impact of the COVID-19 pandemic on tuberculosis rapid access service provision, diagnosis and treatment outcomes
2023Open Access
ASO Visual Abstract: Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)
Annals of Surgical Oncology·2023
page 1 of 8Next →

Frequent Co-authors

Herbert J. Zeh(28), David L. Bartlett(28), Amer H. Zureikat(23), Matthew P. Holtzman(22), James F. Pingpank(16), Steven A. Ahrendt(15), Lekshmi Ramalingam(15), Heather Jones(15), Reetesh K. Pai(12), Yong J. Lee(10), James Pingpank(9), Deepa Magge(7), David L. Bartlett(6), Mazen S. Zenati(6), Nathan Bahary(6), Young‐Sun Lee(5), Marina N. Nikiforova(5), Arun Mavanur(5), Melissa E. Hogg(4), Aatur D. Singhi(4)